![Cheri Walker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cheri Walker
President at Firefly BioWorks, Inc.
Cheri Walker active positions
Companies | Position | Start | End |
---|---|---|---|
Brickbio, Inc.
![]() Brickbio, Inc. Packaged SoftwareTechnology Services Brickbio, Inc. operates as a bioconjugation platform for site-specific, site-selective modification of antibodies and other proteins. The company was founded by John Boyce and James Italia and is headquartered in Woburn, MA. | Director/Board Member | - | - |
Firefly BioWorks, Inc.
![]() Firefly BioWorks, Inc. Medical SpecialtiesHealth Technology Firefly BioWorks, Inc. develops an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. It offers Multiplex Cellular miRNA and Multiplex Circulating miRNA Assays that use Firefly particle technology to enable simultaneous analysis of 68 miRNAs per well; and vacuum manifold for 96 well filter plates. The company was founded by Davide M. Marini and Daniel C. Pregibon in 2009 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
President | - | - |
Career history of Cheri Walker
Statistics
International
United States | 3 |
Operational
Director/Board Member | 2 |
President | 1 |
Sectoral
Technology Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Brickbio, Inc.
![]() Brickbio, Inc. Packaged SoftwareTechnology Services Brickbio, Inc. operates as a bioconjugation platform for site-specific, site-selective modification of antibodies and other proteins. The company was founded by John Boyce and James Italia and is headquartered in Woburn, MA. | Technology Services |
Firefly BioWorks, Inc.
![]() Firefly BioWorks, Inc. Medical SpecialtiesHealth Technology Firefly BioWorks, Inc. develops an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. It offers Multiplex Cellular miRNA and Multiplex Circulating miRNA Assays that use Firefly particle technology to enable simultaneous analysis of 68 miRNAs per well; and vacuum manifold for 96 well filter plates. The company was founded by Davide M. Marini and Daniel C. Pregibon in 2009 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Cheri Walker
- Experience